Pancreatic Cancer Research

ResearcherNanyang Technological UniversityNo recent work listed

Guimiao Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1699-1307; OpenAlex author ID A5106790537. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 5

  1. Biodegradable Polymer-Coated Multifunctional Graphene Quantum Dots for Light-Triggered Synergetic Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acsami.8b16168↗
  2. Biodegradable nanoparticles as siRNA carriers for in vivo gene silencing and pancreatic cancer therapy. Co-author DOI 10.1039/c6tb03116a↗
  3. Biodegradable nanoparticle-mediated K-ras down regulation for pancreatic cancer gene therapy. Co-author DOI 10.1039/c4tb01623h↗
  4. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA. Co-author DOI 10.7150/thno.11335↗
  5. Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes. Co-author DOI 10.1039/c3bm60325c↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ken‐Tye Yong · 5 shared papers, 2014–2019 · strength 0.27
  2. Chengbin Yang · 5 shared papers, 2014–2019 · strength 0.27
  3. Feng Yin · 2 shared papers, 2015–2017 · strength 0.10
  4. Tommy Anderson · 2 shared papers, 2014–2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.